Article Dans Une Revue Pharmacogenomics Journal Année : 2025

Influence of genetic biomarkers on cardiac diseases in childhood cancer survivors: a systematic review

Résumé

Childhood cancer survivors (CCS) often suffer from cardiac disease (CD) after treatment that included anthracycline and radiotherapy involving the heart. However, the variability in CD occurrence cannot be explained solely by these treatments, suggesting the existence of genetic predisposition. We conducted a systematic review searching on Medline-PubMed and Scopus, to identify studies reporting associations between genetic factors and CD in CCS. We included studies published up to 11 April 2023, with no lower limit, and assessed the quality of genetic associations by the Q-genie tool. As a result, 20 studies were included (15 case-control and five cohorts), revealing several genes and variants associated with cardiomyopathy, among which, SLC28A3 -rs7853758, RARG -rs2229774, P2RX7- rs208294 and P2RX7- rs3751143 variants gave the most consistent findings. This review highlights the necessity to establish a set of clinically useful genes and variants to identify patients most at risk of developing cardiomyopathy, and to implement monitoring and prevention strategies.

Fichier principal
Vignette du fichier
2025_LeTeuff_PharmacogenomicsJ.pdf (791.59 Ko) Télécharger le fichier
Origine Publication financée par une institution
Licence

Dates et versions

inserm-05106174 , version 1 (10-06-2025)

Licence

Identifiants

Citer

Naïla Aba, Claire Ducos, Eric Morel, Chiraz El Fayech, Brice Fresneau, et al.. Influence of genetic biomarkers on cardiac diseases in childhood cancer survivors: a systematic review. Pharmacogenomics Journal, 2025, 25 (3), pp.15. ⟨10.1038/s41397-025-00369-y⟩. ⟨inserm-05106174⟩
625 Consultations
100 Téléchargements

Altmetric

Partager

  • More